|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Washington University School of Medicine |
|---|---|
| Information provided by: | Washington University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00513799 |
Purpose
The purpose of this study is to determine the natural history of community-associated Staphylococcus aureus infections in both adult and pediatric patients by monitoring the rate of recurrent infections in those colonized with S. aureus.
In addition, this study will evaluate the efficiency of commonly prescribed decolonization measures in patients presenting with S. aureus skin and soft tissue infections.
| Condition | Intervention |
|---|---|
|
Abscesses Furunculosis Staphylococcus Aureus Infection Staphylococcal Skin Infections |
Drug: Mupirocin ointment Genetic: Chlorhexidine showers Procedure: Bleach baths (dilute) Behavioral: Intensive education on personal hygiene |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Natural History of Community-Associated Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections and an Evaluation of Decolonization Strategies |
| Enrollment: | 300 |
| Study Start Date: | March 2007 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1: Hygiene Education
Intensive education on prevention of skin infections through improvements in personal hygiene (also serves as "control group")
|
Behavioral: Intensive education on personal hygiene
Repeat hygiene methods for 5 days.
|
|
Active Comparator: 2: Hygiene education + mupirocin
Application of mupirocin in the nasal mucosa alone
|
Drug: Mupirocin ointment
Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.
Other Name: Bactroban
Behavioral: Intensive education on personal hygiene
Repeat hygiene methods for 5 days.
|
|
Active Comparator: Education + mupirocin + chlorhexidine
A combination of nasal application of mupirocin and chlorhexidine showers
|
Drug: Mupirocin ointment
Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.
Other Name: Bactroban
Genetic: Chlorhexidine showers
Apply Clorhexidine wash to entire body once daily for 5 days.
Other Name: Hibiclens
Behavioral: Intensive education on personal hygiene
Repeat hygiene methods for 5 days.
|
|
Active Comparator: 4: Education + mupirocin + bleach baths
A combination of nasal application of mupirocin and bathing in dilute bleach water
|
Drug: Mupirocin ointment
Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.
Other Name: Bactroban
Procedure: Bleach baths (dilute)
Pour 2 ounces of bleach into water-filled bath tub. Soak in bath for 15 minutes. Apply once daily for 5 days.
Other Name: Clorox
Behavioral: Intensive education on personal hygiene
Repeat hygiene methods for 5 days.
|
Infections with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) range in severity from superficial skin abscesses to invasive soft tissue infections like cellulitis and pyomyositis. There has been a large increase in the number of patients presenting to our institution with CA-MRSA infections. Colonization with S. aureus (SA) may be linked to the development of infection but data on this phenomenon are limited. The recurrence rate for CA-MRSA soft tissue infections is unknown. A variety of decolonization strategies have been used for infection prophylaxis with varying results, primarily in patients undergoing hemodialysis or surgery. This study seeks to determine the recurrence rate of soft tissue infections among patients with CA-MRSA infections and to determine a reasonable and efficacious decolonization strategy to eradicate CA-MRSA from previously infected patients.
The proposed methods for decolonization will be tested in a randomized controlled trial with four intervention arms. The intervention arms are: (1) intensive education on prevention of skin infections through improvements in personal hygiene (also serves as "control group"), (2) application of mupirocin in the nasal mucosa alone, (3) a combination of nasal application of mupirocin and chlorhexidine showers, and (4) a combination of nasal application of mupirocin and bathing in dilute bleach water. The "control" group as well as the three other arms will receive intensive hygiene education.
Decolonization with mupirocin ointment and chlorhexidine showers or dilute bleach baths in combination are likely to be more successful than either the application of nasal mupirocin ointment alone or hygiene measures alone. It is expected that these decolonization methods will result in a 50% relative reduction in MRSA colonization at 6 months.
Eligibility| Ages Eligible for Study: | 6 Months and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Missouri | |
| Barnes-Jewish Hospital | |
| St. Louis, Missouri, United States, 63110 | |
| St. Louis Children's Hospital | |
| St. Louis, Missouri, United States, 63110 | |
| Principal Investigator: | Bernard C. Camins, MD, MSCR | Assistant Professor of Medicine, Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine |
| Principal Investigator: | Gregory A. Storch, MD | Professor of Medicine and Molecular Microbiology, Chief of Division of Pediatric Infectious Diseases, Department of Medicine, Washington University School of Medicine |
More Information
| Responsible Party: | Bernard Camins, MD, Washington University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00513799 History of Changes |
| Other Study ID Numbers: | 9000C4 |
| Study First Received: | August 8, 2007 |
| Results First Received: | March 2, 2011 |
| Last Updated: | March 31, 2011 |
| Health Authority: | United States: Institutional Review Board |
|
Abscess Furunculosis Skin Diseases, Infectious Staphylococcal Skin Infections Staphylococcal Infections Suppuration Infection Inflammation Pathologic Processes Gram-Positive Bacterial Infections Bacterial Infections Skin Diseases, Bacterial Skin Diseases |
Chlorhexidine gluconate Chlorhexidine Mupirocin Anti-Infective Agents, Local Anti-Infective Agents Therapeutic Uses Pharmacologic Actions Dermatologic Agents Disinfectants Protein Synthesis Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Anti-Bacterial Agents |